Related references
Note: Only part of the references are listed.A Novel, Dose-Adjusted Tacrolimus Trough-Concentration Model for Predicting and Estimating Variance After Kidney Transplantation
Janet Kim et al.
DRUGS IN R&D (2019)
Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: Establishing baseline values
Abbie D. Leino et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
OPTN/SRTR 2017 Annual Data Report: Kidney
A. Hart et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
A Randomized Trial of a Multicomponent Intervention to Promote Medication Adherence: The Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT)
Bethany J. Foster et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Increasing tacrolimus time-in-therapeutic range is associated with superior one-year outcomes in lung transplant recipients
Christopher R. Ensor et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
High tacrolimus trough level variability is associated with rejections after heart transplant
Itai Gueta et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Report from the American Society of Transplantation Psychosocial Community of Practice Adherence Task Force: Real-world options for promoting adherence in adult recipients
Larissa Myaskovsky et al.
CLINICAL TRANSPLANTATION (2018)
Prevalence, Risk Factors, and Impact of Donor-Specific Alloantibodies After Adult Liver Transplantation
Katia Vandevoorde et al.
LIVER TRANSPLANTATION (2018)
Age-specific risk of renal graft loss from late acute rejection or non-compliance in the adolescent and young adult period
Angus G. Ritchie et al.
NEPHROLOGY (2018)
Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection
Kasia A. Sablik et al.
PLOS ONE (2018)
A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology
Candice Roufosse et al.
TRANSPLANTATION (2018)
Intervention of Online Percent Coefficient of Variation Reporting System Reduces the Variability of Tacrolimus Trough Concentration in Kidney Transplant Recipients
C. -Y. Cheng et al.
TRANSPLANTATION PROCEEDINGS (2018)
High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation
Arnaud Del Bello et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Tacrolimus and Single Intraoperative High-dose of Anti-Tlymphocyte Globulins Versus Tacrolimus Monotherapy in Adult Liver Transplantation One-year Results of an Investigator-driven Randomized Controlled Trial
Samuele Iesari et al.
ANNALS OF SURGERY (2018)
Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients
Stephan R. Seibert et al.
CLINICAL TRANSPLANTATION (2018)
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study
S. Tremblay et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development
Chris Wiebe et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Understanding Medication Nonadherence after Kidney Transplant
Thomas E. Nevins et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction
Philip J. O'Connell et al.
TRANSPLANTATION (2017)
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation
David J. Taber et al.
TRANSPLANTATION (2017)
High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime
Henry R. Whalen et al.
TRANSPLANTATION (2017)
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group
James M. Neuberger et al.
TRANSPLANTATION (2017)
The Role of Humoral Alloreactivity in Liver Transplantation: Lessons Learned and New Perspectives
Elaine Y. Cheng
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Wuzhi Tablet (Schisandra sphenanthera Extract) is a Promising Tacrolimus-Sparing Agent for Renal Transplant Recipients Who are CYP3A5 Expressers: a Two-Phase Prospective Study
Jiali Li et al.
DRUG METABOLISM AND DISPOSITION (2017)
The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study
E. Shemesh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant Patients
Dawn L. Goodall et al.
TRANSPLANTATION DIRECT (2017)
High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients
T. Vanhove et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Clinical determinants of calcineurin inhibitor disposition: a mechanistic review
Thomas Vanhove et al.
DRUG METABOLISM REVIEWS (2016)
Effect of Breakfast on the Exposure of the Once-Daily Tacrolimus Formulation in Stable Kidney Transplant Recipients
Frank Stifft et al.
THERAPEUTIC DRUG MONITORING (2016)
A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation
Nauras Shuker et al.
TRANSPLANT INTERNATIONAL (2016)
Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development
Emilio Rodrigo et al.
TRANSPLANTATION (2016)
Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival
Harry M. Gallagher et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
How to handle missed or delayed doses of tacrolimus in renal transplant recipients? A pharmacokinetic investigation
Franck Saint-Marcoux et al.
PHARMACOLOGICAL RESEARCH (2015)
African-American Race Modifies the Influence of Tacrolimus Concentrations on Acute Rejection and Toxicity in Kidney Transplant Recipients
David J. Taber et al.
PHARMACOTHERAPY (2015)
Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients-A Prospective, Randomized Study
Elisabet Storset et al.
TRANSPLANTATION (2015)
Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management
Nauras Shuker et al.
TRANSPLANTATION REVIEWS (2015)
Performance of Modified-Release Tacrolimus After Conversion in Liver Transplant Patients Indicates Potentially Favorable Outcomes in Selected Cohorts
Aisling Considine et al.
LIVER TRANSPLANTATION (2015)
Assessment of Tacrolimus Absorption From the Human Intestinal Tract: Open-Label, Randomized, 4-Way Crossover Study
Daisuke Tsunashima et al.
CLINICAL THERAPEUTICS (2014)
Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure
Ruth Sapir-Pichhadze et al.
KIDNEY INTERNATIONAL (2014)
Medication Level Variability Index Predicts Rejection, Possibly Due to Nonadherence, in Adult Liver Transplant Recipients
Christina Supelana et al.
LIVER TRANSPLANTATION (2014)
Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials
R. Bouamar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
From gut to kidney: Transporting and metabolizing calcineurin-inhibitors in solid organ transplantation
Noel Knops et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
CYP3A5 Genotype Had no Impact on Intrapatient Variability of Tacrolimus Clearance in Renal Transplant Recipients
N. Spierings et al.
THERAPEUTIC DRUG MONITORING (2013)
Improved Adherence to Tacrolimus Once-Daily Formulation in Renal Recipients: A Randomized Controlled Trial Using Electronic Monitoring
Dirk R. J. Kuypers et al.
TRANSPLANTATION (2013)
Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Generic Drug Products by the US Food and Drug Administration
Barbara M. Davit et al.
AAPS JOURNAL (2012)
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Impact of Tacrolimus Intraindividual Variability and CYP3A5 Genetic Polymorphism on Acute Rejection in Kidney Transplantation
Han Ro et al.
THERAPEUTIC DRUG MONITORING (2012)
Combinational Effect of Intestinal and Hepatic CYP3A5 Genotypes on Tacrolimus Pharmacokinetics in Recipients of Living Donor Liver Transplantation
Eunhee Ji et al.
TRANSPLANTATION (2012)
CYP3A5 Genotype Is Not Related to the Intrapatient Variability of Tacrolimus Clearance
Nilufar Pashaee et al.
THERAPEUTIC DRUG MONITORING (2011)
European Society for Organ Transplantation Advisory Committee Recommendations on Generic Substitution of Immunosuppressive Drugs
Teun van Gelder
TRANSPLANT INTERNATIONAL (2011)
Lower Variability of Tacrolimus Trough Concentration After Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients
Ming-Ju Wu et al.
TRANSPLANTATION (2011)
High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation
Lennaert C. P. Borra et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study
Henrik Ekberg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Immunotherapy in Elderly Transplant Recipients A Guide to Clinically Significant Drug Interactions
Dirk R. J. Kuypers
DRUGS & AGING (2009)
Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study
Chang Liu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference
Pierre Wallemacq et al.
THERAPEUTIC DRUG MONITORING (2009)
Circadian and time-dependent variability in tacrolimus pharmacokinetics
Sung-In Park et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2007)
Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose
I Bekersky et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects
I Bekersky et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Share Paper
